SABS - Financial Reports List - SAB Biotherapeutics, Inc. - IntrinsicAlpha

SAB Biotherapeutics, Inc. SABS

Healthcare - Biotechnology - NASDAQ - US

$ 1.84

-7.2 %

$ 17.1 M

Market Cap

-0.46

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	-3.40%	5.43%
Quarterly Report	Q4	8-K	2024-12-31	-62.40%	50.15%	46.97%
Annual Report	FY	10-K	2024-12-31	-40.94%	19.17%	-12.70%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-102.84%	-112.47%
Quarterly Report	Q2	8-K	2024-06-30	207.70%	-6.61%	-57.52%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	31.66%	-53.89%
Quarterly Report	Q4	8-K	2023-12-31	-85.88%	-190.26%	-140.12%
Annual Report	FY	10-K	2023-12-31	-90.63%	-125.14%	-31.67%
Quarterly Report	Q3	8-K	2023-09-30	-64.69%	19.58%	31.82%
Quarterly Report	Q2	8-K	2023-06-30	-98.65%	-44.07%	1.01%

1